Anthera Pharmaceuticals, Inc. Common Stock
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch ANTH and buy or sell other stocks, ETFs, and their options commission-free!About ANTH
Anthera Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of medicines to treat serious and life-threatening diseases. It offers Sollpura and blisibimod to treat diseases such as exocrine pancreatic insufficiency and Immunoglobulin A nephropathy.
CEOJohn Craig Thompson, MBA
CEOJohn Craig Thompson, MBA
Employees21
Employees21
HeadquartersHouston, Texas
HeadquartersHouston, Texas
Founded2004
Founded2004
Employees21
Employees21
ANTH Key Statistics
Market cap2.62K
Market cap2.62K
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume6.43K
Average volume6.43K
High today$0.0001
High today$0.0001
Low today$0.0001
Low today$0.0001
Open price—
Open price—
Volume64.29K
Volume64.29K
52 Week high$0.001
52 Week high$0.001
52 Week low$0.00
52 Week low$0.00
Stock Snapshot
As of today, Anthera Pharmaceuticals, Inc. Common Stock(ANTH) shares are valued at $0.00. The company's market cap stands at 2.62K.
On 2026-10-25, Anthera Pharmaceuticals, Inc. Common Stock(ANTH) shares started trading at —, with intraday highs of $0.00 and lows of $0.00.
Trading activity shows a volume of 64.29K, compared to an average daily volume of 6.43K.
The stock's 52-week range extends from a low of $0.00 to a high of $0.00.
The stock's 52-week range extends from a low of $0.00 to a high of $0.00.